Follow The 13GDs: Balchem Corp Has Another Bullish Trade, Brown Capital Management Llc Bought Stake!

Follow The 13GDs: Balchem Corp Has Another Bullish Trade, Brown Capital Management Llc Bought Stake!

The New Brown Capital Management Llc Holding in Balchem Corp

Brown Capital Management Llc filed with the SEC SC 13G/A form for Balchem Corp. The form can be accessed here: 000139834416019428. As reported in Brown Capital Management Llc’s form, the filler as of late owns 10.95% or 3,462,882 shares of the Materials–company.

Balchem Corp stake is a new one for the for this institutional investor and it was filed because of activity on September 30, 2016. We feel this shows Brown Capital Management Llc’s positive view for the stock. For a institutional investor managing $7.02 billion in assets and having 34+ active experts, we at Financialmagazine have no doubt the buy is a bullish signal.

Balchem Corp Institutional Sentiment

Latest Security and Exchange filings show 168 investors own Balchem Corp. The institutional ownership in Q3 2015 is high, at 113.71% of the outstanding shares. This is increased by 9874557 the total institutional shares. 35965154 were the shares owned by these institutional investors. In total 21 funds opened new Balchem Corp stakes, 81 increased stakes. There were 18 that closed positions and 46 reduced them.

4 managers had the stock in their top Ten. Notable investors are: .

Brown Capital Management Llc is an institutional investor bullish on Balchem Corp, owning 3241290 shares as of Q3 2015 for 3.38% of its portfolio. Tamro Capital Partners Llc owns 343956 shares or 2.37% of its portfolio. NY Sophrosyne Capital Llc have 0.48% of their stock portfolio for 900 shares. Further, Bard Associates Inc reported stake worth 1.99% of its US stock portfolio. The MN Summit Creek Advisors Llc owns 318556 shares. Balchem Corp is 3.14% of the manager’s US portfolio.

Business Profile

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. Its SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, grain-based snacks and cereal-based ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies-based nutritional products. Specialty Products segment provides ethylene oxide and propylene oxide products. Its Industrial Products segment provides Choline Chloride and methylamines. The Company sells its products through its own sales force, independent distributors and sales agents.

SEC Form 13G is required when the filer owns between (5% and 20%) of a company and plans to hold it only as a passive investor. In case the filler intend to exert control and the stake’s exceeds 20%, then 13D Form must be filed. These filings can NOT be a precursor to “change of control” events such as hostile takeovers, company breakups or others.

Brown Capital Management Llc website.

Insitutional Activity: The institutional sentiment increased to 1.22 in Q2 2016. Its up 0.08, from 1.14 in 2016Q1. The ratio is positive, as 11 funds sold all Balchem Corporation shares owned while 54 reduced positions. 14 funds bought stakes while 65 increased positions. They now own 24.68 million shares or 4.84% less from 25.93 million shares in 2016Q1.

Henderson Grp Public Ltd Liability Co reported 409,516 shares or 0.2% of all its holdings. Finemark National Bank has 32 shares for 0% of their US portfolio. Assetmark reported 420 shares or 0% of all its holdings. Clinton Group Inc owns 8,255 shares or 0.02% of their US portfolio. Raymond James Fincl Svcs Advisors has invested 0.03% of its portfolio in Balchem Corporation (NASDAQ:BCPC). State Street owns 607,298 shares or 0% of their US portfolio. Cim Inv Mangement holds 0.1% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 4,195 shares. Amer Gru Inc reported 23,439 shares or 0% of all its holdings. Gradient Limited has 45 shares for 0% of their US portfolio. Deutsche Bank & Trust Ag has invested 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). First Ltd Partnership, a Illinois-based fund reported 12,022 shares. Fdx owns 3,524 shares or 0.01% of their US portfolio. Blackrock Invest Management Ltd Liability Co owns 131,198 shares or 0.01% of their US portfolio. Gsa Cap Prtn Llp accumulated 0.02% or 6,400 shares. Palisade Lc Nj holds 181,807 shares or 0.39% of its portfolio.

Insider Transactions: Since May 19, 2016, the stock had 0 buys, and 7 sales for $4.44 million net activity. Houston Matthew David also sold $271,320 worth of Balchem Corporation (NASDAQ:BCPC) shares. 16,600 shares with value of $1.03M were sold by ROSSI DINO A on Wednesday, July 13. 1,500 shares were sold by MCMILLAN EDWARD, worth $104,619 on Friday, September 2. 12,000 shares were sold by Backus William A., worth $823,680.

Analysts await Balchem Corporation (NASDAQ:BCPC) to report earnings on November, 1.

About 175,179 shares traded hands or 42.04% up from the average. Balchem Corporation (NASDAQ:BCPC) has risen 23.15% since March 2, 2016 and is uptrending. It has outperformed by 14.89% the S&P500.

Balchem Corporation is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The company has a market cap of $2.49 billion. The Firm operates in four divisions: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. It has a 44.95 P/E ratio. The Company’s SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, grain snacks and cereal ingredients.

More important recent Balchem Corporation (NASDAQ:BCPC) news were published by: Fool.com which released: “Balchem Corporation Revenue Drops on Weak Energy Demand” on February 29, 2016, also Marketwatch.com published article titled: “Balchem Corp. NASDAQ: BCPC”, Quotes.Wsj.com published: “News Balchem Corp.BCPC” on February 12, 2011. More interesting news about Balchem Corporation (NASDAQ:BCPC) was released by: Fool.com and their article: “Why Balchem Corporation’s Shares Popped 14% Today” with publication date: February 02, 2016.

According to Zacks Investment Research, “Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients for the food, feed and medical sterilization industries. They operate in two business segments, the micro-encapsulation of performance ingredients and the repackaging and marketing of high quality specialty gases. They sell their products through their own sales force, independent distributors and sales agents.”

BCPC Company Profile

Balchem Corporation (Balchem), incorporated on January 30, 1967, is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Firm operates in four divisions: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products. The Firm sells its products through its own sales force, independent distributors and sales agents. The Company’s SensoryEffects segment provides creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, ready-to-eat cereals, grain snacks and cereal ingredients. ANH segment provides basic choline chloride, and microencapsulation and chelation technologies nutritional products. Specialty Products segment provides ethylene oxide and propylene oxide products. The Company’s Industrial Products segment provides Choline Chloride and methylamines. The Company’s subsidiaries include SensoryEffects, Inc. (SE), SensoryEffects Cereal Systems, Inc. (SECS), BCP Ingredients, Inc. (BCP) and Aberco, Inc. (Aberco).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment